Artículos por temáticas

Validation of the Caregiver Analysis of Reported Experiences with Swallowing Disorders (CARES) Screening Tool for Neurodegenerative Disease

Shune S, Gray LT, Perry S, Kosty D, Namasivayam-MacDonald A.

Am J Speech Lang Pathol. 2025 Mar 10;34(2):633-645. doi: 10.1044/2024_AJSLP-24-00253. Epub 2025 Jan 24.

Exploring tele-speech therapy: A scoping review of interventions, applications, benefits, and challenges

Moulaei K, Dinari F, Hosseini M, Almasi S, Sabet B, Anabestani R, Afrash MR.

Int J Med Inform. 2025 Mar;195:105784. doi: 10.1016/j.ijmedinf.2025.105784. Epub 2025 Jan 8.

Revealing Three-Dimensional Printing Technology Advances for Oral Drug Delivery: Application to Central-Nervous-System-Related Diseases

Paipa-Jabre-Cantu SI, Rodriguez-Salvador M, Castillo-Valdez PF.

Pharmaceutics. 2025 Mar 31;17(4):445. doi: 10.3390/pharmaceutics17040445.

The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment

Sun H, Hao Y, Liu H, Gao F.

Front Immunol. 2025 Mar 11;16:1525623. doi: 10.3389/fimmu.2025.1525623. eCollection 2025.

Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study

Smith HT, Das S, Fettiplace J, von Maltzahn R, Troke PJF, McLaughlin MM, Jones DE, Kremer AE.

Hepatol Commun. 2025 Feb 19;9(3):e0635. doi: 10.1097/HC9.0000000000000635. eCollection 2025 Mar 1.

Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View

Di Sarno A, Romano F, Arianna R, Serpico D, Lavorgna M, Savastano S, Colao A, Di Somma C.

Metabolites. 2025 Apr 18;15(4):282. doi: 10.3390/metabo15040282.

A scoping review on motor imagery-based rehabilitation: Potential working mechanisms and clinical application for cognitive function and depression

Hu Y, Li Y, Leung AYM, Li J, Mei X, Montayre J, Tao R, Yorke J.

Clin Rehabil. 2025 Apr;39(4):504-523. doi: 10.1177/02692155241313174. Epub 2025 Jan 15.

Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study

Isaacson SH, Espay AJ, Pahwa R, Agarwal P, Shill HA, Hui J, Dashtipour K, Lew M, Qin P, Formella AE, Ceresoli-Borroni G, LeWitt PA; InfusON Study Group.

J Parkinsons Dis. 2025 Mar;15(2):361-373. doi: 10.1177/1877718X241310727. Epub 2025 Jan 29.

KG2ML: Integrating Knowledge Graphs and Positive Unlabeled Learning for Identifying Disease-Associated Genes

Kumar P, Metzger VT, Purushotham ST, Kedia P, Bologa CG, Lambert CG, Yang JJ.

medRxiv [Preprint]. 2025 Mar 17:2025.03.17.25323906. doi: 10.1101/2025.03.17.25323906.

Validation of automated detection of REM sleep without atonia using in-laboratory and in-home recordings

Levendowski DJ, Chahine LM, Lewis SJG, Finstuen TJ, Galbiati A, Berka C, Mosovsky S, Parikh H, Anderson J, Walsh CM, Lee-Iannotti JK, Neylan TC, Strambi LF, Boeve BF, St Louis EK.

J Clin Sleep Med. 2025 Mar 1;21(3):583-592. doi: 10.5664/jcsm.11488.

Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis

Dattola S, Ielo A, Varone G, Cacciola A, Quartarone A, Bonanno L.

Front Aging Neurosci. 2025 Apr 10;17:1547727. doi: 10.3389/fnagi.2025.1547727. eCollection 2025.

Smartphone Application for Spastic Ataxias Cross-Sectional Validation of a Newly Developed Smartphone App for Remote Monitoring in Spastic Ataxias

Willemse IHJ, Mellone S, Tacconi C, Ilg W, Schüle R, Synofzik M, Nonnekes JH, van de Warrenburg BPC.

Cerebellum. 2025 Mar 24;24(3):71. doi: 10.1007/s12311-025-01820-3.

The complex interplay between sleep and neurodegenerative diseases: An epidemiological view

Bergmann M, Tschiderer L, Seekircher L, Santamaria J, Provini F.

Neuroepidemiology. 2025 May 15:1-28. doi: 10.1159/000546316. Online ahead of print.

Recent advances in blood-brain barrier-on-a-chip models

Vetter J, Palagi I, Waisman A, Blaeser A.

Acta Biomater. 2025 May 1;197:1-28. doi: 10.1016/j.actbio.2025.03.041. Epub 2025 Mar 22.

Targeting mitophagy in neurodegenerative diseases

Antico O, Thompson PW, Hertz NT, Muqit MMK, Parton LE.

Nat Rev Drug Discov. 2025 Apr;24(4):276-299. doi: 10.1038/s41573-024-01105-0. Epub 2025 Jan 14.